Skip to main content

Table 4 Categories of GI tools by guideline characteristic

From: Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines

Guideline characteristic (n GI tools) GI tool category (n, %)
Patient Clinician Implementation Evaluation
Condition
 Diabetes (130) 37 (28.5) 64 (49.2) 20 (15.4) 9 (6.9)
 Stroke (100) 26 (26.0) 63 (63.0) 8 (8.0) 3 (3.0)
 Heart failure (88) 15 (17.0) 48 (54.5) 14 (15.9) 11 (12.5)
 Asthma (50) 15 (30.0) 30 (60.0) 4 (8.0) 1 (2.0)
 Arthritis (35) 12 (34.4) 13 (37.1) 6 (17.1) 4 (11.4)
 Depression (42) 5 (11.9) 20 (47.6) 10 (23.8) 7 (16.7)
 Colorectal cancer (19) 3 (15.8) 1 (5.3) 4 (21.1) 11 (57.9)
Country
 United States (199) 62 (31.2) 121 (60.8) 16 (8.0) 0 (0.0)
 United Kingdom (151) 28 (18.5) 38 (25.2) 41 (27.2) 44 (29.1)
 Canada (90) 21 (23.3) 60 (66.7) 8 (8.9) 1 (1.1)
 Australia (11) 1 (9.1) 9 (81.8) 0 (0.0) 1 (9.1)
 International group (8) 1 (12.5) 7 (87.5) 0 (0.0) 0 (0.0)
 Singapore (3) 0 (0.0) 2 (66.7) 1 (33.3) 0 (0.0)
 Brazil (2) 0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0)
 Finland (0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Spain (0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Organization
 Government agency (166) 39 (23.5) 48 (28.9) 40 (24.1) 39 (23.5)
 Professional society (135) 23 (17.0) 97 (71.9) 13 (9.6) 2 (1.5)
 Academic institution (66) 29 (46.0) 31 (52.6) 6 (9.5) 0 (0.0)
 Disease foundation (63) 18 (27.3) 37 (56.1) 4 (6.1) 4 (6.1)
 Non-profit agency (33) 4 (12.1) 25 (75.8) 3 (9.1) 1 (3.0)
 International group (1) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
Overall (464) 113 (24.4) 239 (51.5) 66 (14.2) 46 (9.9)
  1. The proportion of GI tools reflects the total number of guidelines by condition, country, and organization